Skip to main content
. 2022 Oct 24;8(1):132–147. doi: 10.1177/23969873221126027

Table 4.

QASC Europe: patient treatment and discharge outcomes.

Pre N = 3464 Post N = 3257 Difference in proportion (95% CI) b p a
n (%) n (%)
Treatment
 Patient received intravenous thrombolysis 813 (23) 738 (23) −1.2% (−3.4%, 0.99%) 0.2770
 Patient treated in a stroke unit at any time during their stay 2904 (84) 2974 (91) 4.1% (2%, 6.2%) <0.0001
Discharge outcomes
Discharge destination
  Home 1965 (61) 1799 (61) n/a 0.6774
  Rehabilitation facility 402 (13) 363 (12)
  Long-term care/nursing home 198 (6.2) 208 (7.1)
  Other hospital 323 (10) 293 (9.9)
  Deceased 294 (9.2) 280 (9.5)
  (Missing) 253 (7.3) 308 (9.5)
Discharge modified Rankin Score
  0: No symptoms at all 489 (15) 390 (13) n/a 0.0328
  1: No significant disability despite symptoms 572 (18) 505 (17)
  2: Slight disability 413 (13) 413 (14)
  3: Moderate disability 472 (15) 402 (14)
  4: Moderately severe disability 521 (16) 522 (18)
  5: Severe disability 450 (14) 437 (15)
  6: Deceased 294 (8.5) 280 (9.5)
  mRS ⩾ 2 2150 (67) 2054 (70) 1.6% (−0.65%, 3.9%) 0.1614
  (Missing) 243 (7.0) 308 (9.5)
Able to walk unassisted on discharge
  Yes 1791 (53) 1799 (56) 2.9% (0.68%, 5.2%) 0.0105
  No 1562 (47) 1410 (44)
  (Missing) 111 (3.2) 48 (1.5)
Duration of hospital stay (days)
  Median (Q1, Q3) 8 (5, 12) 8 (5, 12) −0.20 (−0.53, 0.14) 0.1257

n/a: due to the multiple nominal distribution of this variable it was not appropriate to calculate pre-post difference in proportions.

a

Mixed effects logistic regression controlling for age, sex, NIHSS and correlation within site and country.

b

Estimated marginal mean difference in proportion from mixed effects model, standard errors for confidence interval obtained using delta method.

Bold indicates significant values